Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) — Cash Flow Reinvestment Rate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a Cash Flow Reinvestment Rate of 0.48x as of September 2025, reinvesting CN¥56.87 Million (capex CN¥56.87 Million ) from operating cash flow of CN¥117.38 Million. Check how high is Zhangzhou Pientzehuang Pharmaceutical Co's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2001–2025)
Historical reinvestment intensity for Zhangzhou Pientzehuang Pharmaceutical Co Ltd across 24 annual periods. Explore 600436 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)
Year-by-year capital reinvestment analysis for Zhangzhou Pientzehuang Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 600436 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 7.00x | CN¥539.00 Million | CN¥77.03 Million | CN¥339.80 Million | ▲ +617.2% |
| 2024 | 0.98x | CN¥1.28 Billion | CN¥1.31 Billion | CN¥1.07 Billion | ▼ -3.0% |
| 2023 | 1.01x | CN¥2.22 Billion | CN¥2.21 Billion | CN¥141.87 Million | ▲ +8.9% |
| 2022 | 0.92x | CN¥6.35 Billion | CN¥6.87 Billion | CN¥175.37 Million | ▲ +81.2% |
| 2021 | 0.51x | CN¥235.49 Million | CN¥462.27 Million | CN¥92.17 Million | ▲ +72.2% |
| 2020 | 0.30x | CN¥434.05 Million | CN¥1.47 Billion | CN¥419.01 Million | ▲ +139.9% |
| 2018 | 0.12x | CN¥75.52 Million | CN¥612.31 Million | CN¥74.24 Million | ▼ -37.6% |
| 2017 | 0.20x | CN¥133.69 Million | CN¥676.93 Million | CN¥51.87 Million | ▼ -78.9% |
| 2016 | 0.94x | CN¥369.26 Million | CN¥394.54 Million | CN¥90.97 Million | ▲ +140.9% |
| 2015 | 0.39x | CN¥118.68 Million | CN¥305.51 Million | CN¥78.86 Million | ▲ +297.3% |
| 2014 | 0.10x | CN¥25.87 Million | CN¥264.50 Million | CN¥25.87 Million | ▼ -81.7% |
| 2013 | 0.53x | CN¥146.54 Million | CN¥274.34 Million | CN¥146.54 Million | ▼ -44.1% |
| 2012 | 0.96x | CN¥155.22 Million | CN¥162.40 Million | CN¥155.22 Million | ▲ +526.1% |
| 2011 | 0.15x | CN¥35.56 Million | CN¥232.95 Million | CN¥35.56 Million | ▼ -19.4% |
| 2010 | 0.19x | CN¥38.90 Million | CN¥205.41 Million | CN¥38.90 Million | ▼ -17.3% |
| 2009 | 0.23x | CN¥29.67 Million | CN¥129.52 Million | CN¥29.67 Million | ▼ -95.1% |
| 2008 | 4.65x | CN¥58.50 Million | CN¥12.57 Million | CN¥58.50 Million | ▲ +162.4% |
| 2007 | 1.77x | CN¥106.47 Million | CN¥60.04 Million | CN¥106.47 Million | ▲ +932.2% |
| 2006 | 0.17x | CN¥8.71 Million | CN¥50.70 Million | CN¥8.71 Million | ▼ -65.6% |
| 2005 | 0.50x | CN¥34.54 Million | CN¥69.06 Million | CN¥34.54 Million | ▲ +358.9% |
| 2004 | 0.11x | CN¥10.75 Million | CN¥98.67 Million | CN¥10.75 Million | ▼ -77.3% |
| 2003 | 0.48x | CN¥15.56 Million | CN¥32.36 Million | CN¥15.56 Million | ▲ +419.2% |
| 2002 | 0.09x | CN¥9.77 Million | CN¥105.45 Million | CN¥9.77 Million | ▼ -47.6% |
| 2001 | 0.18x | CN¥11.64 Million | CN¥65.84 Million | CN¥11.64 Million | — |